Assessment of effectiveness of deworming options in recently weaned beef cattle utilizing different anthelmintic programs in the southeast.

This study evaluated the effects of three different anthelmintic strategies on animal performance and anthelmintic effectiveness in weaned calves during a 42-d preconditioning period. The study was conducted at four locations over 2 yr and included a total of 797 recently weaned spring-born calves (initial BW 260 ± 37.7 kg). At the start of each year, at each location, calves were weaned and randomly assigned to one of four treatments: 1) oxfendazole ( ORAL ); 2) transdermal eprinomectin ( POUR ); 3) both anthelmintic treatments ( BOTH ); and 4) the control ( CONT ) group who did not receive treatment. Anthelmintic was applied per the manufacturer recommendation, the transdermal eprinomectin was administered at 1 mL per 10 kg and oxfendazole was administered orally at 1 mL per 50 kg. Weights were measured at the start of the study (day 0) and again at the end of the preconditioning phase (day 42). Fecal samples were collected at the start of the study prior to treatment application (day 0) and again on day 14. Rumen fluid was collected at the start of the study prior to treatment (day 0) and again on day 6. There were treatment effects for all performance metrics ( P < 0.001). All treatments had greater weight gain and value of weight gained ( P < 0.024), and all three strategies did not differ from each other ( P > 0.420). On day 0, there were no ( P = 0.795) treatment effects detected for fecal eggs per gram ( EPG ) counts. On day 14, there were ( P < 0.001) treatment effects for EPG counts with feces from CONT calves containing greater ( P < 0.014) EPG than feces from treated calves. EPG in feces from BOTH calves did not differ ( P > 0.123) from the other two treated groups and feces from POUR calves tended ( P = 0.052) to contain greater EPG counts than feces from ORAL calves. Volatile fatty acids were similar across treatments on days 0 and 6 ( P > 0.115). Butyrate tended ( P = 0.063) to be lower in ORAL on day 6. These results suggest that using eprinomectin and oxfendazole in combination was an effective strategy for reducing EPG and improving performance during a 42-d preconditioning phase.